Emphasizing its advanced cardiac care capabilities, Apollo Hospitals Navi Mumbai (AHNM), successfully treated two cases – one of pulmonary embolism and another of myocardial infarction – saving the ...

They contribute to endothelial dysfunction, promote atherosclerosis, disrupt glucose metabolism, and elevate blood pressure — all critical pathways in development of NCDs (specially hypertension, ...

The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered by ...

Controversies in the Treatment of Ischemia-Reperfusion Injury, ” will focus on past and current strategies for reducing the myocardial damage caused by IRI following percutaneous coronary intervention ...

A new study reveals that heart attack survivors could greatly reduce their risk of a second event by starting combination ...

Ten years after learning their polygenic risk score, patients had fewer events—perhaps due to greater use of statin therapy.

Not everyone is sold on the benefits of early ezetimibe use, especially given the modest effect seen in IMPROVE-IT.

The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered, potentially paving the way for innovative treatments that align with the natural ...

The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered by ...

Adverse cardiovascular outcomes can be predicted in patients with coronary artery disease with a risk score that includes mental stress outcomes.

Join Drs Maureen McMahon and Michael Garshick as they discuss cardiovascular disease in patients with systemic lupus erythematosus, focusing on hidden risk and challenging clinical scenarios.

Patients with COPD and established cardiovascular disease have more MACEs and seek less preventive cardiac care than patients with CVD alone.